Sucampo Pharmaceuticals, an international biopharmaceutical company, has announced that Jan Smilek, chief financial officer (CFO) and vice president, finance, has resigned to pursue other opportunities. The company will initiate search for a new CFO.
Smilek joined Sucampo in February 2008 as vice president of finance and corporate controller. In August 2008, he was appointed acting CFO and in December 2009 he was appointed CFO. Prior to joining Sucampo, Smilek was the senior director of finance at Vanda Pharmaceuticals.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more